Perfluorobutane

Generic Name
Perfluorobutane
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C4F10
CAS Number
355-25-9
Unique Ingredient Identifier
SE4TWR0K2C
Background

Perflubutane has been used in trials studying the diagnostic of Liver Mass, Liver Diseases, Liver Metastasis, Portal Hypertension, and Peripheral Artery Disease. It is a cardiovascular drug designed to enable ultrasound to compete more effectively with nuclear stress testing; currently the leading procedure for detecting coronary heart disease.

Indication

适用于肝脏肿块病变的超声显影。

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC

Not Applicable
Completed
Conditions
Microwave Ablation
Hepatocellular Carcinoma
Interventions
Drug: Perfluorobutane
First Posted Date
2021-10-05
Last Posted Date
2021-12-21
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
21
Registration Number
NCT05068076
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound

First Posted Date
2017-08-10
Last Posted Date
2024-05-29
Lead Sponsor
Thomas Jefferson University
Target Recruit Count
80
Registration Number
NCT03245255
Locations
🇺🇸

Thomas Jefferson University and Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Ischemic Memory Imaging With Myocardial Contrast Echocardiography

Early Phase 1
Conditions
Myocardial Ischemia
Interventions
Drug: Sonazoid
First Posted Date
2017-01-04
Last Posted Date
2018-08-23
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
40
Registration Number
NCT03009266
Locations
🇺🇸

OHSU, Portland, Oregon, United States

Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma

First Posted Date
2016-11-18
Last Posted Date
2020-03-30
Lead Sponsor
University of Southern California
Target Recruit Count
5
Registration Number
NCT02968680
Locations
🇺🇸

USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Superb Microvascular Imaging in Focal Nodular Hyperplasia

First Posted Date
2016-04-14
Last Posted Date
2019-12-17
Lead Sponsor
Samsung Medical Center
Target Recruit Count
62
Registration Number
NCT02737865
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection

First Posted Date
2016-04-11
Last Posted Date
2023-03-06
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
8
Registration Number
NCT02733029
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI

Phase 3
Withdrawn
Conditions
Liver Mass
Liver Metastasis
Interventions
Drug: Sonazoid
First Posted Date
2016-01-08
Last Posted Date
2017-09-13
Lead Sponsor
Northeastern Ohio Radiology Research and Education Fund
Registration Number
NCT02651090
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy